A detailed history of Monaco Asset Management Sam transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Monaco Asset Management Sam holds 75,000 shares of MRVI stock, worth $402,750. This represents 0.09% of its overall portfolio holdings.

Number of Shares
75,000
Previous 200,000 62.5%
Holding current value
$402,750
Previous $1.43 Million 56.49%
% of portfolio
0.09%
Previous 0.23%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$6.84 - $9.73 $855,000 - $1.22 Million
-125,000 Reduced 62.5%
75,000 $623,000
Q2 2024

Aug 07, 2024

BUY
$6.87 - $11.34 $287,502 - $474,567
41,849 Added 26.46%
200,000 $1.43 Million
Q1 2024

May 09, 2024

SELL
$5.11 - $8.76 $782,131 - $1.34 Million
-153,059 Reduced 49.18%
158,151 $1.37 Million
Q4 2023

Feb 07, 2024

BUY
$4.7 - $9.87 $1.46 Million - $3.07 Million
311,210 New
311,210 $2.04 Million

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $706M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Monaco Asset Management Sam Portfolio

Follow Monaco Asset Management Sam and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monaco Asset Management Sam, based on Form 13F filings with the SEC.

News

Stay updated on Monaco Asset Management Sam with notifications on news.